Pierre Dodey

663 total citations
22 papers, 469 citations indexed

About

Pierre Dodey is a scholar working on Molecular Biology, Genetics and Organic Chemistry. According to data from OpenAlex, Pierre Dodey has authored 22 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Organic Chemistry. Recurrent topics in Pierre Dodey's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers), Chemical Synthesis and Analysis (7 papers) and Neuropeptides and Animal Physiology (5 papers). Pierre Dodey is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers), Chemical Synthesis and Analysis (7 papers) and Neuropeptides and Animal Physiology (5 papers). Pierre Dodey collaborates with scholars based in France, Belgium and United States. Pierre Dodey's co-authors include G. Gacel, Didier Pruneau, Françis Petit, P. Rossignol, Bernárd P. Roques, Jean‐Marie Zajac, Pierre Bélichard, F. BELLAMY, Jean‐Luc Paquet and Jean‐Michel Luccarini and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Pierre Dodey

22 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Dodey France 10 297 190 131 124 55 22 469
Elisabeth Greiner United States 14 209 0.7× 175 0.9× 91 0.7× 50 0.4× 97 1.8× 22 518
Tadahiro Shikimi Japan 11 181 0.6× 134 0.7× 13 0.1× 110 0.9× 69 1.3× 52 422
Timothy P. Burkholder United States 13 301 1.0× 90 0.5× 161 1.2× 33 0.3× 42 0.8× 23 506
Chie Hatori Japan 14 279 0.9× 73 0.4× 300 2.3× 321 2.6× 45 0.8× 19 747
Attila Egyed Hungary 12 160 0.5× 42 0.2× 34 0.3× 67 0.5× 44 0.8× 25 344
Hiroe Sawai Japan 9 162 0.5× 48 0.3× 106 0.8× 262 2.1× 19 0.3× 11 413
Masanobu Komiya Japan 10 146 0.5× 27 0.1× 70 0.5× 165 1.3× 18 0.3× 18 376
Charles E. Odya United States 13 255 0.9× 114 0.6× 18 0.1× 239 1.9× 19 0.3× 20 525
April Smith‐Torhan United States 11 238 0.8× 219 1.2× 62 0.5× 29 0.2× 114 2.1× 12 461
Marija Dulović Serbia 13 176 0.6× 63 0.3× 83 0.6× 12 0.1× 55 1.0× 13 462

Countries citing papers authored by Pierre Dodey

Since Specialization
Citations

This map shows the geographic impact of Pierre Dodey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Dodey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Dodey more than expected).

Fields of papers citing papers by Pierre Dodey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Dodey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Dodey. The network helps show where Pierre Dodey may publish in the future.

Co-authorship network of co-authors of Pierre Dodey

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Dodey. A scholar is included among the top collaborators of Pierre Dodey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Dodey. Pierre Dodey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luccarini, Jean‐Michel, et al.. (2012). From Bradykinin B2 Receptor Antagonists to Orally Active and Selective Bradykinin B1 Receptor Antagonists. Journal of Medicinal Chemistry. 55(6). 2574–2584. 13 indexed citations
3.
Amblard, Muriel, Gilles Subra, Pierre Dodey, et al.. (2000). A Rational Approach to the Design and Synthesis of a New Bradykinin B1 Receptor Antagonist. Journal of Medicinal Chemistry. 43(12). 2387–2394. 23 indexed citations
4.
Pruneau, Didier, et al.. (1999). Pharmacological profile of LF 16-0687, a new potent non-peptide bradykinin B2 receptor antagonist. Immunopharmacology. 43(2-3). 187–194. 77 indexed citations
5.
Amblard, Muriel, Gilbert Bergé, Didier Pruneau, et al.. (1999). Design and Synthesis of Potent Bradykinin Agonists Containing a Benzothiazepine Moiety. Journal of Medicinal Chemistry. 42(20). 4185–4192. 56 indexed citations
6.
Amblard, Muriel, Gilbert Bergé, Monique Calmès, et al.. (1999). Synthesis and Characterization of Bradykinin B2 Receptor Agonists Containing Constrained Dipeptide Mimics. Journal of Medicinal Chemistry. 42(20). 4193–4201. 23 indexed citations
7.
Amblard, Muriel, Gilbert Bergé, Pierre Dodey, et al.. (1998). Synthesis and pharmacological evaluation of dimer derivatives of the bradykinin receptor antagonist HOE‐140. Journal of Peptide Research. 52(1). 1–14. 6 indexed citations
8.
Dodey, Pierre, et al.. (1995). AN IMPROVED SYNTHESIS OF 4-HYDROXY AND 4′-METHOXYBIPHENYL-2-CARBOXYLIC ACIDS. Organic Preparations and Procedures International. 27(4). 500–503. 1 indexed citations
9.
Dodey, Pierre, et al.. (1995). Synthesis and biological evaluation of new arylthiophene analogs of DuP 753. Bioorganic & Medicinal Chemistry Letters. 5(1). 15–18. 3 indexed citations
10.
Nouet, Sandrine, Pierre Dodey, Patrice Renaut, et al.. (1994). Properties of [3H]LF 7-0156, a new nonpeptide antagonist radioligand for the type 1 angiotensin II receptor.. Molecular Pharmacology. 46(4). 693–701. 5 indexed citations
11.
LECLERC, G., et al.. (1994). An efficient synthesis of chlorinated imidazoles throughtert‐butyldimethylsilyloxy derivatives. Journal of Heterocyclic Chemistry. 31(5). 1121–1123. 3 indexed citations
12.
BELLAMY, F., et al.. (1992). Enantioselective synthesis of four isomeric building blocks useful in the synthesis of 2-nor-leukotriene analogues. Tetrahedron Asymmetry. 3(3). 355–358. 5 indexed citations
13.
BELLAMY, F., et al.. (1991). (Benzoylphenyl)piperidines: a new class of immunomodulators. Journal of Medicinal Chemistry. 34(5). 1545–1552. 4 indexed citations
14.
BELLAMY, F., et al.. (1990). A new, short and efficient synthesis of both enantiomers of carnitine. Tetrahedron Letters. 31(50). 7323–7326. 38 indexed citations
15.
Zajac, Jean‐Marie, G. Gacel, Françis Petit, et al.. (1983). Deltakephalin, Tyr-D-Thr-Gly-Phe-Leu-Thr: A new highly potent and fully specific agonist for opiate δ-receptors. Biochemical and Biophysical Research Communications. 111(2). 390–397. 142 indexed citations
17.
Guilard, Roger, et al.. (1981). Synthèse d'acétyl‐6 et benzoyl‐6 indoles. Journal of Heterocyclic Chemistry. 18(7). 1365–1371. 3 indexed citations
18.
Martin, Maryvonne L., Françoise Mabon, B. Gautheron, & Pierre Dodey. (1977). Etude par RMN 1H et 13C, de la stereochimie de [3] ferrocenophanols α,γ-disubstitues et de l'isomerisation conformationnelle des cations formes au cours de substitutions nucleophiles. Journal of Organometallic Chemistry. 124(2). 175–180. 2 indexed citations
19.
Dodey, Pierre & B. Gautheron. (1975). Stereochimie de derives ferroceniques heteropontes chiraux. Journal of Organometallic Chemistry. 94(3). 441–447. 4 indexed citations
20.
Dodey, Pierre & B. Gautheron. (1975). Mecanisme pe substitutions nucleophiles sur des ferrocenophanols. Tetrahedron Letters. 16(34). 2981–2984. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026